For the readers of ChinaBio® Today, stories about the astonishing growth of China’s pharmaceutical industry are not news. Nevertheless, two articles have appeared this week that underscore just how large this phenomenon is. The Washington Post ran a story that was not specific for biopharma, but talked about the growing number of returnees.  A cover story from Chemical & Engineering News discusses in detail the China CRO situation, providing a lot of color behind the headline statistics. More details...

Stock Symbol: (NYSE: WX)